MRD / Regn No. : TL/20-21/00837 Date : 10/06/2026
Patient Name : ANURAG LAL Age & Gender : 39 Yrs. / Male
Contact No. : 9412742529 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NONE Referred By :
   
Subjective : T2DM NEWLY DETECTED,HBA1C 13% - 5.9% - NOW AROUND 7.5%,WT LOSS MAINTAINED,RETUNRED TO NORTH INDIA - FOOD CHANGED,COMPLETELY SEDENTARY OFFICE WORK,WILL START EXERCISE AFTER WINTER OVER
Objective : JUN 26- HB- 15/HBA1C- 6.62,FBS-119/PP- 133,TC- 191/TG- 134/LDL- 115.3/HDL- 48.9,AST- 22.5/ALT- 44.4,VIT B12- 366/VIT D- 26.6,T3- 98.7/T4- 9.35/TSH- 2.13,CREAT- 0.72
Plan : CONSIDER STATIN IF LIPIDS STILL HIGH AFTER HBA1C CLOSE TO 7%,CAN FINISH OLD MEDS BY TAKING 2 TABS TOGETHER IN MORNING OR AFTER BKF AND AFTER LUNCH  
S# Generic (Trade) Name Route Dosage Usage Duration
1 NERVIHENZ ORAL 0-1-0 ALT DAY
 4 MTHS
2 TABLET CHOLECALCIFEROL 60,000IU
DRISE 60K 		ORAL 1/WEEK ANYTIME OF DAY
 4 MTHS
3 ONDERO DM 5/10/500 MG ORAL 1-0-0 ABF
 4 MTHS
       
Refill : 0 / Substitution:    
Education :
Next Visit : 06/May/2026
Tests Suggested For Next Visit : HBA1C / FBS / PPBS /LIPID PROFILE > 4 MTHS
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription

Powered By: